Actions of Calcium Channel Blockers on Vascular Proteoglycan Synthesis: Relationship to Atherosclerosis

References

• AdlerAIStrattonIMNeilHAAssociation of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational studyBMJ20003214121910938049
   PubMed Web of Science ®Google Scholar
• AgrotisALittlePJSaltisJDihydropyridine Ca2+ channel antagonists inhibit the salvage pathway for DNA synthesis in human vascular smooth muscle cellsEur J Pharmacol1993244269758458401
   PubMed Web of Science ®Google Scholar
• AntmanEMStonePHMullerJECalcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effectsAnn Intern Med198093875856255848
   PubMed Web of Science ®Google Scholar
• ArrowsmithJECampbellSFCrossPELong-acting dihyropryridine calcium antagonists. 1,2-alkoxymethyl derivatives incorporating basic substituentsJ Med Chem19862916967022943898
   PubMed Web of Science ®Google Scholar
• BallingerMNigroJFrontanillaKRegulation of glycosaminoglycan structure and atherogenesisCell Mol Life Sci200461129630615170508
   PubMed Web of Science ®Google Scholar
• BarbierOTorraIPDuguayYPleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosisArterioscler Thromb Vasc Biol2002227172612006382
   PubMed Web of Science ®Google Scholar
• BellostaSBerniniFFerriNDirect vascular effects of HMG-CoA reductase inhibitorsAtherosclerosis1998137SupplS10199694549
   PubMedGoogle Scholar
• CamejoGHurt-CamejoEWiklundOAssociation of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basisAtherosclerosis1998139205229712326
   PubMed Web of Science ®Google Scholar
• CandidoRAllenTJLassilaMIrbesartan but not amlodipine suppresses diabetes-associated atherosclerosisCirculation200410915364215023892
   PubMed Web of Science ®Google Scholar
• ChaitAWightTNInteraction of native and modified low-density lipoproteins with extracellular matrixCurr Opin Lipidol2000114576311048888
   PubMed Web of Science ®Google Scholar
• ChangMYPotter-PerigoSTsoiCOxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding propertiesJ Biol Chem200027547667310671509
   PubMed Web of Science ®Google Scholar
• ChenZIshibashiSPerreySTroglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDLArterioscler Thromb Vasc Biol200121372711231916
   PubMed Web of Science ®Google Scholar
• ClaudelTLeibowitzMDFievetCReduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptorProc Natl Acad Sci U S A20019826101511226287
   PubMed Web of Science ®Google Scholar
• CollinsARMeehanWPKintscherUTroglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient miceArterioscler Thromb Vasc Biol2001213657111231915
   PubMed Web of Science ®Google Scholar
• DuezHChaoYSHernandezMReduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in miceJ Biol Chem200227748051712377786
   PubMed Web of Science ®Google Scholar
• FaberMThe human aorta: sulfate-containing polyuronides and the deposition of cholesterolArch Pathol Lab Med19494834250
   Google Scholar
• FagnenGPhamantuNTBocquetJInhibition of transmembrane calcium influx induces decrease in proteoglycan synthesis in immature rat Sertoli cellsJ Cell Biochem1999763223110618648
   PubMed Web of Science ®Google Scholar
• FigueroaJEVijayagopalPAngiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding propertiesAtherosclerosis2002162261811996945
   PubMed Web of Science ®Google Scholar
• FleckensteinAPeter Harris Award lecture. History and prospects in calcium antagonist researchJ Mol Cell Cardiol199022241512192067
   PubMed Web of Science ®Google Scholar
• GaedePVedelPLarsenNMultifactorial intervention and cardiovascular disease in patients with type 2 diabetesN Engl J Med20033483839312556541
   PubMed Web of Science ®Google Scholar
• GoldmannSStoltefussJBornLDetermination of the absolute configuration of the active amlodipine enantiomer as (−)-S: a correctionJ Med Chem199235334141388206
   PubMed Web of Science ®Google Scholar
• GuillonGBalestreMNMouillacBMechanisms of phospholipase C activation: a comparison with the adenylate cyclase systemBiochimie198769351633115315
   PubMed Web of Science ®Google Scholar
• GustafssonMBorenJMechanism of lipoprotein retention by the extracellular matrixCurr Opin Lipidol2004155051415361785
   PubMed Web of Science ®Google Scholar
• HernandezRHArmas-HernandezMJVelascoMCalcium antagonists and atherosclerosis protection in hypertensionAm J Ther2003104091414624278
   PubMedGoogle Scholar
• Hurt-CamejoEOlssonUWiklundOCellular consequences of the association of apoB lipoproteins with proteoglycans. Potential contribution to atherogenesisArterioscler Thromb Vasc Biol1997171011179194748
   PubMed Web of Science ®Google Scholar
• JensenTThe HOPE study and diabetes. Heart Outcomes Prevention EvaluationLancet2000355118110791397
   PubMedGoogle Scholar
• JukemaJWZwindermanAHvan BovenAJEvidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study GroupArterioscler Thromb Vasc Biol199616425308630669
   PubMed Web of Science ®Google Scholar
• KadarAGlaszTDevelopment of atherosclerosis and plaque biologyCardiovasc Surg200191092111250172
   PubMedGoogle Scholar
• KohrogiHHorioSAndoMNifedipine inhibits human bronchial smooth muscle contractions induced by leukotrienes C4 and D4, prostaglandin F2 alpha, and potassiumAm Rev Respir Dis19851322993043861111
   PubMedGoogle Scholar
• LehtoSRonnemaaTHaffnerSMDyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDMDiabetes199746135499231662
   PubMed Web of Science ®Google Scholar
• LiACBrownKKSilvestreMJPeroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient miceJ Clin Invest20001065233110953027
   PubMed Web of Science ®Google Scholar
• LibbyPInflammation in atherosclerosisNature20024208687412490960
   PubMed Web of Science ®Google Scholar
• LichtlenPRHugenholtzPGRafflenbeulWRetardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT)Lancet19903351109131971861
   PubMed Web of Science ®Google Scholar
• LittlePJTannockLOlinKLProteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLsArterioscler Thromb Vasc Biol200222556011788461
   PubMed Web of Science ®Google Scholar
• LuksaJJosicDPodobnikBSemi-preparative chromatographic purification of the enantiomers S-(−)-amlodipine and R-(+)-amlodipineJ Chromatogr B Biomed Sci Appl1997693367759210441
   PubMed Web of Science ®Google Scholar
• LusisAJAtherosclerosisNature20004072334111001066
   PubMed Web of Science ®Google Scholar
• LutgensEvan SuylenRJFaberBCAtherosclerotic plaque rupture: local or systemic process?Arterioscler Thromb Vasc Biol20032321233014512372
   PubMed Web of Science ®Google Scholar
• MacMahonSPetoRCutlerJBlood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasLancet1990335765741969518
   PubMed Web of Science ®Google Scholar
• ManciaGBrownMCastaigneAOutcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT)Hypertension200341431612623939
   PubMed Web of Science ®Google Scholar
• MeyersCDTannockLRWightTNStatin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDLJ Lipid Res20034421526012923222
   PubMed Web of Science ®Google Scholar
• MotroMShemeshJCalcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diureticsHypertension20013714101311408386
   PubMed Web of Science ®Google Scholar
• NigroJBallingerMDilleyRFenofibrate modifies human vascular smooth muscle proteoglycans and reduces LDL bindingDiabetologia20044721051315592811
   PubMed Web of Science ®Google Scholar
• NigroJBallingerMLOsmanNAnti-atherogenic role of peroxisome proliferator activated receptor ligandsCurr Cardiol Rev2005In press
   Google Scholar
• NigroJDilleyRJLittlePJDifferential effects of gemfibrozil on migration, proliferation and proteoglycan production in human vascular smooth muscle cellsAtherosclerosis20021621192911947905
   PubMed Web of Science ®Google Scholar
• OlssonUBondjersGCamejoGFatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteinsDiabetes1999486162210078565
   PubMed Web of Science ®Google Scholar
• PerlmanRLCossiAFRoleLWMechanisms of ionophore-induced catecholamine secretionJ Pharmacol Exp Ther198021324167365686
   PubMed Web of Science ®Google Scholar
• PittBByingtonRPFurbergCDEffect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT InvestigatorsCirculation200010215031011004140
   PubMed Web of Science ®Google Scholar
• RadhakrishnamurthyBSrinivasanSRVijayagopalPArterial wall proteoglycans – biological properties related to pathogenesis of atherosclerosisEur Heart J199011Suppl E148572226523
   PubMedGoogle Scholar
• SchonherrEJarvelainenHTSandellLJEffects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cellsJ Biol Chem19912661764071894644
   PubMed Web of Science ®Google Scholar
• SchonherrEKinsellaMGWightTNGenistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cellsArch Biochem Biophys1997339353619056268
   PubMed Web of Science ®Google Scholar
• ShahPKMechanisms of plaque vulnerability and ruptureJ Am Coll Cardiol20034115S22S12644336
   PubMed Web of Science ®Google Scholar
• ShanahanCMCaryNRMetcalfeJCHigh expression of genes for calcification-regulating proteins in human atherosclerotic plaquesJ Clin Invest19949323934028200973
   PubMed Web of Science ®Google Scholar
• Shimizu-HirotaRSasamuraHMifuneMRegulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptorsJ Am Soc Nephrol20011226091511729229
   PubMed Web of Science ®Google Scholar
• SidhuJSKaposztaZMarkusHSEffect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitusArterioscler Thromb Vasc Biol200424930415001452
   PubMed Web of Science ®Google Scholar
• SimonAGariepyJMoyseDDifferential effects of nifedipine and co-amilozide on the progression of early carotid wall changesCirculation200110329495411413085
   PubMed Web of Science ®Google Scholar
• SkalenKGustafssonMRydbergEKSubendothelial retention of atherogenic lipoproteins in early atherosclerosisNature2002417750412066187
   PubMed Web of Science ®Google Scholar
• SrinivasanSRXuJHVijayagopalPInjury to the arterial wall of rabbits produces proteoglycan variants with enhanced low-density lipoprotein-binding propertyBiochim Biophys Acta19931168158668504150
   PubMed Web of Science ®Google Scholar
• StaelsBCardiovascular biology: a cholesterol tetherNature200241769970112066168
   PubMed Web of Science ®Google Scholar
• TannockLLittlePJWightTNArterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced binding to LDLJ Lipid Res2002431495711792734
   PubMed Web of Science ®Google Scholar
• TannockLRLittlePJTsoiCThiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycansDiabetologia2004478374315071727
   PubMed Web of Science ®Google Scholar
• TaoZSmartFWFigueroaJEElevated expression of proteoglycans in proliferating vascular smooth muscle cellsAtherosclerosis199713517199430366
   PubMed Web of Science ®Google Scholar
• TsienRYNew calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structuresBiochemistry19801923964046770893
   PubMed Web of Science ®Google Scholar
• [UKPDS] UK Prospective Diabetes Study (UKPDS) GroupIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet1998a35283753
   PubMed Web of Science ®Google Scholar
• [UKPDS] UK Prospective Diabetes Study GroupTight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38Br Med J1998b31770313
   PubMedGoogle Scholar
• VasileESimionescuMSimionescuNVisualization of the binding, endocytosis, and transcytosis of low-density lipoprotein in the arterial endothelium in situJ Cell Biol1983961677896853599
   PubMed Web of Science ®Google Scholar
• VijayagopalPSubramaniamPEffect of calcium channel blockers on proteoglycan synthesis by vascular smooth muscle cells and low density lipoprotein-proteoglycan interactionAtherosclerosis20011573536011472734
   PubMed Web of Science ®Google Scholar
• WatersDLesperanceJFrancetichMA controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosisCirculation1990821940532242520
   PubMed Web of Science ®Google Scholar
• WilliamsKJTabasIThe response-to-retention hypothesis of early atherogenesisArterioscler Thromb Vasc Biol199515551617749869
   PubMed Web of Science ®Google Scholar
• WilliamsKJTabasIThe response-to-retention hypothesis of atherogenesis reinforcedCurr Opin Lipidol1998947149812202
   PubMed Web of Science ®Google Scholar
• YutaniCImakitaMIshibashi-UedaHCoronary atherosclerosis and interventions: pathological sequences and restenosisPathol Int1999492739010365846
   PubMed Web of Science ®Google Scholar
• ZanchettiABondMGHennigMAbsolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA)J Hypertens20042212011215167456
   PubMed Web of Science ®Google Scholar
• ZanchettiARoseiEADal PaluCThe Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thicknessJ Hypertens1998161667769856368
   PubMed Web of Science ®Google Scholar